RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,577,170 | -32.1% | 8,867,750 | -18.9% | 0.00% | – |
| Q2 2023 | $14,108,509 | -5.9% | 10,936,829 | -3.7% | 0.00% | – |
| Q1 2023 | $14,994,056 | -17.3% | 11,359,133 | -6.0% | 0.00% | – |
| Q4 2022 | $18,125,694 | +28.6% | 12,083,796 | +1.2% | 0.00% | – |
| Q3 2022 | $14,092,000 | +19.0% | 11,942,196 | +14.0% | 0.00% | – |
| Q2 2022 | $11,842,000 | -56.6% | 10,479,170 | +14.7% | 0.00% | -100.0% |
| Q1 2022 | $27,305,000 | +14.1% | 9,132,210 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $23,925,000 | -27.4% | 9,028,114 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $32,973,000 | -16.3% | 9,083,253 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $39,390,000 | +28.6% | 9,076,112 | +1.4% | 0.00% | 0.0% |
| Q1 2021 | $30,627,000 | -4.3% | 8,955,089 | -2.1% | 0.00% | 0.0% |
| Q4 2020 | $32,009,000 | +49.8% | 9,145,599 | +2.7% | 0.00% | 0.0% |
| Q3 2020 | $21,364,000 | +29.5% | 8,901,382 | -1.3% | 0.00% | 0.0% |
| Q2 2020 | $16,500,000 | +19.9% | 9,015,560 | +2.2% | 0.00% | 0.0% |
| Q1 2020 | $13,767,000 | -27.2% | 8,825,350 | -0.1% | 0.00% | 0.0% |
| Q4 2019 | $18,908,000 | +21.3% | 8,835,237 | +6.0% | 0.00% | 0.0% |
| Q3 2019 | $15,590,000 | -16.8% | 8,337,044 | +16.2% | 0.00% | 0.0% |
| Q2 2019 | $18,733,000 | +17.0% | 7,177,249 | +15.2% | 0.00% | 0.0% |
| Q1 2019 | $16,011,000 | +50.4% | 6,230,024 | +34.6% | 0.00% | – |
| Q4 2018 | $10,645,000 | -55.3% | 4,628,553 | -37.6% | 0.00% | -100.0% |
| Q3 2018 | $23,802,000 | +14.1% | 7,414,959 | +0.6% | 0.00% | 0.0% |
| Q2 2018 | $20,852,000 | -9.9% | 7,368,175 | +12.7% | 0.00% | 0.0% |
| Q1 2018 | $23,150,000 | -4.1% | 6,539,590 | +5.2% | 0.00% | 0.0% |
| Q4 2017 | $24,130,000 | +69.3% | 6,218,931 | +10.8% | 0.00% | 0.0% |
| Q3 2017 | $14,254,000 | -13.6% | 5,612,031 | -7.1% | 0.00% | 0.0% |
| Q2 2017 | $16,489,000 | -12.5% | 6,039,790 | +6.1% | 0.00% | 0.0% |
| Q1 2017 | $18,837,000 | +67.3% | 5,691,035 | +20.3% | 0.00% | 0.0% |
| Q4 2016 | $11,259,000 | -36.8% | 4,730,690 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $17,828,000 | +73.0% | 4,857,542 | +5.1% | 0.00% | 0.0% |
| Q2 2016 | $10,308,000 | +10.0% | 4,622,246 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $9,367,000 | -9.6% | 4,503,064 | +31.7% | 0.00% | 0.0% |
| Q4 2015 | $10,363,000 | +28.5% | 3,420,101 | +4.7% | 0.00% | – |
| Q3 2015 | $8,067,000 | -20.6% | 3,265,830 | +3.1% | 0.00% | -100.0% |
| Q2 2015 | $10,165,000 | -7.5% | 3,166,713 | +2.9% | 0.00% | 0.0% |
| Q1 2015 | $10,984,000 | +61.6% | 3,076,919 | +2.8% | 0.00% | – |
| Q4 2014 | $6,797,000 | -6.0% | 2,994,546 | -19.6% | 0.00% | -100.0% |
| Q3 2014 | $7,228,000 | -51.6% | 3,725,785 | -9.5% | 0.00% | 0.0% |
| Q2 2014 | $14,946,000 | -6.3% | 4,117,277 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $15,959,000 | +48.5% | 4,113,181 | +9.0% | 0.00% | 0.0% |
| Q4 2013 | $10,750,000 | -37.4% | 3,771,942 | -21.3% | 0.00% | -50.0% |
| Q3 2013 | $17,165,000 | +12.8% | 4,794,858 | +5.2% | 0.00% | 0.0% |
| Q2 2013 | $15,222,000 | – | 4,557,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |